Levels of myeloid-derived suppressor cell-like cells in early sepsis: a comparative study with non-septic patients

Read full text Summarise with VIRAT
Authors: Lijing Jia, Huawei Wang, Ling Long, Chen Ge, Ze Zhang, H Y Chen, Jing Wang, Heling Zhao
Cited by: 0
References: 47

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells with immunosuppressive functions. While early expansion of MDSCs may be protective in various pathological states, their accumulation and role might differ in sepsis. This study aimed to compare the differences in circulating myeloid cells with MDSC phenotypes and their subsets between septic and non-septic patients in the early stage. Methods: /low cells (herein referred to as MDSC-like cells) and their subsets (M-MDSC-like and PMN-MDSC-like cells). Levels of arginase-1 (ARG-1) and inducible nitric oxide synthase (iNOS) were measured. Clinical data were collected. All patients were followed for 28 days to record mortality. Results: Sixty patients were enrolled (sepsis group: n=38; non-sepsis group: n=22). No significant differences were found in gender, age, APACHE II score, ICU length of stay, or 28-day mortality between the two groups. However, the Charlson Comorbidity Index (CCI) was higher in the sepsis group (P = 0.005). Compared to the non-sepsis group, septic patients had significantly lower percentages of total MDSC-like cells and M-MDSC-like cells (P = 0.006; P = 0.003), while PMN-MDSC-like cells showed no difference. ARG-1 levels were higher in the sepsis group (P = 0.030). Furthermore, the sepsis group exhibited significantly elevated levels of IL-6, CRP, PCT, and SOFA scores (P

Fields of Study & Subjects

Immune cells in cancer Sepsis Diagnosis and Treatment Inflammation biomarkers and pathways

Publication details

Journal / source
Frontiers in Immunology
Volume
17
Pages
1763005–1763005
Publication date
31 March 2026
Language
EN